Fundraising FoxGabriel Investment Syndicate — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Carcinotech produces bioprinted tumor models combining patient-derived biological material with automated workflows to generate reproducible tumor tissue systems for drug discovery and testing.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesEdinburgh, GB
Lorna(Chief Scientific Officer)
Co-investorsAlba EquityTRICAPITALBritish Business BankEos AdvisoryInvesting Women AngelsInvestment Fund for Scotland+4 more
Metacarpal builds body-powered, multi-articulating upper-limb prosthetic hands designed to be waterproof, durable, and reliable without charging.
HardwareHealthtechMedical Devices
Co-investorsOxford Technology ManagementOxfordScottish Enterprise
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.